Mikroliz Therapeutic Bacteriophage Bank (MTBB)

is established in Turkey which currently has
over 1500 phages against mainly ESKAPE (Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and
Enterobacter spp.)

Featured products

View all

  • Patents

    Mikroliz holds a patent in Acinetobacter baumannii bacteriophage and many others pending

    Learn more 

  • Awards

    Mikroliz has awarded many times from various organizations. View our success story.

    Learn more 

  • About Us

    Mikroliz, is a preclinical biotechnology company to treat multidrug-resistant bacterial infections. We have established Turkey's bacteriophage bank.

    Learn More